Sebastian Payne

A Partner at Deloitte leading a team of Life Science specialists and focusing in Life Science Risk Advisory with over 20 years of experience in LSHC consultancy. Assisting organisations with insight and strategy delivery, in the face of significant Life Science regulatory and technological change.
Since June 2014 the lead for the Deloitte’s Business Services collaboration with the European Medicines Agency and has overseen a number of Deloitte supported projects at the Agency. The leader of Deloitte CORE (Centre of Regulatory Excellence for Life Science) from 2016-2020, A global initiative, which supports Life Science companies implement systems and processes for current and emerging Life Science regulation. Current areas of interest include GxP, Pharmacovigilance, ISO-IDMP and the new Clinical Trials Regulation.